Extracorporeal support: improves donor renal graft function after cardiac death

A Rojas-Pena1, J L Reoma, E Krause

  • 1General Surgery Department, Division of Transplantation, University of Michigan Health System, Ann Arbor, MI, USA. alvaror@umich.edu

Insights

Extracorporeal support after cardiac death (ECS-DCD) can improve kidney function after cardiac arrest. This technique may help more organs from donors after cardiac death (DCD) become viable for transplantation.

Area of Science:

  • Transplantation immunology
  • Organ preservation
  • Nephrology

Background:

  • Donors after cardiac death (DCD) offer a potential solution to expand the deceased donor organ pool.
  • However, delayed graft function and primary nonfunction in DCD kidneys limit their utilization.
  • Extracorporeal support after cardiac death (ECS-DCD) has emerged as a strategy to mitigate these complications.

Purpose of the Study:

  • To evaluate the immediate and acute renal function of kidneys from different donor types.
  • To compare the efficacy of conventional rapid recovery versus ECS in DCD kidney recovery.
  • To assess the impact of varying warm ischemia times on DCD kidney function post-transplantation.

Main Methods:

  • Kidneys from DCD donors (recovered conventionally or with ECS) and living donors (LVD) were transplanted into nephrectomized swine.
  • Warm ischemia times of 10 and 30 minutes were investigated for DCD kidneys.
  • ECS-DCD kidneys underwent 90 minutes of perfusion prior to cold storage (4-6 hours) and transplantation.
  • Post-transplant assessments included renal vascular resistance (RVR), urine output (UO), urine protein concentration (UrPr), and creatinine clearance (CrCl) over 4 hours.

Main Results:

  • All transplanted kidney grafts demonstrated adequate renal blood flow during the 4-hour assessment period.
  • Renal vascular resistance (RVR) returned to baseline levels only in the LVD group, remaining elevated in all DCD groups.
  • While urine output exceeded 50 mL/h in most DCD groups, the DCD group with 30 minutes of warm ischemia (DCD-30) exhibited significantly reduced urine output (6.8 mL/h).
  • The DCD-30 group also showed lower creatinine clearance (0.9 mL/min) and higher urine protein concentration (>200 mg/dL) compared to other DCD groups.

Conclusions:

  • Normothermic extracorporeal support (ECS) can effectively resuscitate kidneys, rendering them transplantable even after 30 minutes of cardiac arrest and warm ischemia.
  • ECS-DCD shows promise in improving the viability and function of DCD kidneys, potentially increasing their utilization in transplantation.
  • The duration of warm ischemia remains a critical factor influencing post-transplant renal function in DCD kidneys, even with ECS intervention.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...